Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

Virology

Volumn 229, Issue 1, 1997, Pages 143-154

  Cranage, M P ^a   Whatmore, A M ^a   Sharpe, S A ^a   Cook, N ^a   Polyanskaya, N ^a   Leech, S ^a   Smith, J D ^a   Rud, E W ^b   Dennis, M J ^a   Hall, G A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MACACA; MUCOSA; NONHUMAN; PRIORITY JOURNAL; RECTUM; SIMIAN IMMUNODEFICIENCY VIRUS; SUPERINFECTION; VACCINATION; VIRUS ATTENUATION;

ANIMALIA; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0031550781     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8419     Document Type: Article

References (42)

1. Anon (1996). Statistics from the Centers for Disease Control and Prevention. AIDS 10, 117-119.
2. Anon (1995). PHLS AIDS Centre-Communicable Disease Surveillance Centre and Scottish Centre for Infection and Environmental Health. Unpublished Quarterly Surveillance Tables No. 29.
3. Adachi, A., Koenig, S., Gendelman, H. E., Daugherty, D., Gattoni-Celli, S., Fauci, A. S., and Martin, M. A. (1987). Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61, 209-213.
4. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B., and Stott, E. J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344.
5. Baba, T. W., Jeong, Y. S., Penninck, D., Bronson, R., Greene, M. F., and Ruprecht, R. M. (1995). Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
6. Bogers, W. M. J. M., Niphuis, H., ten Haaft, P., Laman, J. D., Koornstra, W., and Heeney, J. L. (1995). Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: Consequences of challenge. AIDS 9, F13-F18.
7. Clements, J. E., Montelaro, R. C., Zink, M. C., Amedee, A. M., Miller, S., Trichel., A. M., Jagerski, B., Hauer, D., Martin, L. N., Bohm, R. P., and Murphey-Corb, M. (1995). Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J Virol. 69, 2737-2744.
8. Clerici, M., Clark, E. A., Polacino, P., Axberg, I., Kuller, L. R., Casey, N. I., Morton, W. R., Shearer, G. M., and Benveniste, R.E. (1994). T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391-1395.
9. Cranage, M. P., Baskerville, A., Ashworth, L. A. E., Dennis, M., Cook, N., Cook, R., Sharpe, S. A., Rose, J., Kitchin, P., and Greenaway, P. J. (1992a). Mucosal infection and vaccine studies with macaque SIV Vaccine Res. 1, 311-318.
10. Cranage, M. P., Baskerville, A., Ashworth, L. A. E., Dennis, M., Cook, N., Sharpe, S., Farrar, G., Rose, J., Kitchin, P. A., and Greenaway, P. J. (1992b). Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339, 273-274.
11. Cranage, M. P., Polyanskaya, N., McBride, B., Cook, N., Ashworth, L. A. E., Dennis, M., Baskerville, A., Greenaway, P. J., Corcoran, T., Kitchin, P., Rose, J., Murphey-Corb, M., Desrosiers, R. C., Stott, E. J., and Farrar, G. H. (1993). Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9, 13-22.
12. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., and Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
13. Fleming, S. C., Kapembwa, M. S., MacDonald, T. T., and Griffin, G. E. (1992). Direct in vitro infection of human intestine with HIV-1. AIDS 6, 1099-1104.
14. + nef-specific cytotoxic T cells in vaccinated macaques. Nature Med. 1, 1167-1173.
15. Kärber, G. (1931). Beitrag zur kollektiven behandlung pharmakologischer reihenvesuche. Arch. Exp. Pathol. Pharmakol. 162, 956-959.
16. Kent, K. A., Kitchin, P., Mills, K. H. G., Page, M., Taffs, F., Corcoran, T., Silvera, P., Flanagan, B., Powell, C., Rose, J., Ling, C., Aubertin, A-M., and Stott, E. J. (1994). Passive immunization of cynomolgus macaques with immune serum or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Res. Hum. Retroviruses 10, 189-194.
17. Kitchin, P.A., Almond, N., Szotyori, Z., Fromholc, C. E., McAlpine, L., Silvera, P., Stott, E. J., Cranage, M., Baskerville, A., and Schild, G. (1990a). The use of the polymerase chain reaction for the detection of simian immunodeficiency virus in experimentally infected macaques. J. Virol. Methods 28, 85-100.
18. 251 (32H isolate) in cynomolgus macaques for use as a challenge in vaccination studies. In "Animal Models in AIDS" (H. Schellekens and M. C. Horzinek, Eds.), pp. 115-129. Elsevier Science Publishers B. V., Amsterdam.
19. Lehner, T., Bergmeier, L. A., Tao, L., Panagiotidi, C., Klavinskis, L. S, Hussain, L., Ward, R. G., Meyers, N., Adams, S. E., Gearing, A. J. H., and Brookes, R. (1994). Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J. Immunol. 153, 1858-1868.
20. Lehner, T., Wang, Y., Cranage, M., Bergmeier, L. A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., Brooks, R, Klavinskis, L., Jones, I., Doyle, C., and Ward, R. (1996). Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2, 767-775.
21. Letvin, N. L., Li, J., Halloran, M., Cranage, M. P., Rud, E. W., and Sodroski, J. (1995). Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69, 4569-4571.
22. Li, J., Lord, C. I., Haseltine, W., Letvin, N. L., and Sodroski, J. (1992). Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoprotein. J. Acq. Immune Defic. Syndr. 5, 639-646.
23. Lohman, B. L., Miller, C. J., and McChesney, M. B. (1995). Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155, 5855-5860.
24. Marthas, M. L., Sujipto, S., Higgins, J., Lohman, B., Torten, J., Luciw, P.A., Marx, P.A., and Pederson, N. C. (1990). Immunization with a live attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64, 3694-3700.
25. Mathijs, J. M., Hing, M., Grierson, J., Dwyer, D. E., Goldschmidt, C., Cooper, D. A., and Cunningham, A. L. (1988). HIV infection of rectal mucosa. Lancet 1, 1111.
26. Miller, M. D., Yamamoto, H., Hughes, A. L., Watkins, D. I., and Letvin, N. L. (1991). Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. J. Immunol. 147, 320-329.
27. Miller, C. J., Marthas, M.,Torten, J., Alexander, N. J., Moore, J. P., Doncel, G. F., and Hendrickx, A. G. (1994). Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68, 6391-6400.
28. Nelson, J. A., Wiley, C. A., Reynolds-Kohler, C., Reese, C. E., Margaretten, W., and Levy, J. A. (1988). Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1, 259-262.
29. Pauza, C. D., Malkovsky, M., and Salvato, M. S. (1994). SIV transmission across the mucosal barrier. AIDS Res. Hum. Retroviruses 10(Suppl. 1), 7-10.
30. Putkonen, P., Thorstensson, R., Albert, J., Hild, K., Norrby, E., Biberfeld, P., and Biberfeld, G. (1990). Infection of cynomolgus monkeys with HIV-2 protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4, 783-789.
31. Putkonen, P., Nilsson, C., Mäkitalo, B., Biberfeld, G., Thorstensson, R., Cranage, M., and Rud, E. (1996). Immunization with live attenuated SIVmac can protect macaques against mucosal infection with SIVsm. In "Vaccines 96," pp. 235-241. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Rose, J., Silvera, P., Flanagan, B., Kitchin, P., and Almond, N. (1995). The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J. Virol. Methods 51, 229-239.
33. Rud, E. W., Cranage, M., Yon, J., Quirk, J., Ogilvie, L., Cook, N., Webster, S., Dennis, M., and Clarke, B. E. (1994). Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 75, 529-543.
34. Sabin, A. B. (1992). Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal port of entry. Proc. Natl. Acad. Sci. USA 89, 8852-8855.
35. Spira, A. I., Marx, P. A., Patterson, B. K., Mahoney, J., Koup, R. A., Wolinsky, S. M., and Ho, D.D. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183, 215-225.
36. Stott, E. J., Kitchin, P. A., Page, M., Flanagan, B., Taffs, L. F., Chan, W. L., Mills, K. H. G., Silvera, P., and Rodgers, A. (1991). Anti-cell antibody in macaques. Nature 353, 393.
37. Stott, E. J., Almond, N., West, W., Kent, K., Cranage, M. P., and Rud, E. W. (1994). Protection against simian immunodeficiency virus infection of macaques by cellular or viral antigens. In "Neuvieme Colloque Des Cent Gardes" (M. Girard and L. Vallette, Eds.), pp. 219-224. Foundation Marcel Merieux, Lyon.
38. Venet, A, and Walker, B. D. (1993). Cytotoxic T-cell epitopes in HIV/SIV infection. AIDS 7(Suppl. 1), 117-126.
39. Wakrim, L., LeGrand, R., Vaslin, B., Cheret, A., Matheux, F., Theodoro, F., Roques, P., Nicol-Jourdain, I., and Dormont, D. (1996). Superinfection of HIV-2 preinfected macaques after rectal exposure to a primary isolate of SIVmac251. Virology 221, 260-270.
40. Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W., and Cranage, M. P. (1995). Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69, 5117-5123.
41. Wyand, M. S., Manson, K. H., Garcia-Moll, M., Montefiori, D., and Desrosiers, R. C. (1996). Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70, 3724-3733.
42. Yahi, N., Baghdiguian, S., Moreau, H., and Fantini, J. (1992). Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelium HT29 cells. J. Virol. 66, 4848-4854.